(Q39190953)

English

Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy

scientific article published on 18 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jui-An Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sheng-Uei Fang

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chien-Ling Su

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chia-Jung Hsiao

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chun-Chao Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Yuh-Feng Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Chao-Wen Cheng

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

18 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

29.e1-11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Therapeutic options in the management of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NF-kappaB-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

The changing natural history of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Stress induction of GRP78/BiP and its role in cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Endoplasmic reticulum stress: an unrecognized actor in solid organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Upregulation of GRP78 in renal cell carcinoma and its significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Herp is dually regulated by both the endoplasmic reticulum stress-specific branch of the unfolded protein response and a branch that is shared with other cellular stress pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Cyclin D as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

A HIF-1alpha-related gene involved in cell protection from hypoxia by suppression of mitochondrial function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

G1 cell-cycle control and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Participation of DNA repair in the response to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Living with or without cyclins and cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

PERK mediates cell-cycle exit during the mammalian unfolded protein response

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Activation and clinical significance of the unfolded protein response in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Targeting GRP78 to enhance melanoma cell death.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.10.006

7 January 2021

Identifiers

10.1016/J.UROLONC.2012.10.006

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39190953&oldid=1812173838"